{"id":"https://openalex.org/W2283053264","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.7576","title":"Epidermal growth factor receptor (EGFR) immunohistochemistry: Comparison of antibodies (Abs) and cut points to predict benefit from gefitinib in a phase III placebo-controlled study in advanced non-small cell lung cancer (NSCLC)","display_name":"Epidermal growth factor receptor (EGFR) immunohistochemistry: Comparison of antibodies (Abs) and cut points to predict benefit from gefitinib in a phase III placebo-controlled study in advanced non-small cell lung cancer (NSCLC)","publication_year":2007,"publication_date":"2007-06-20","ids":{"openalex":"https://openalex.org/W2283053264","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.7576","mag":"2283053264"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2007.25.18_suppl.7576","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.7576","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.7576","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054931755","display_name":"Rafa\u0142 Dziadziuszko","orcid":"https://orcid.org/0000-0001-8080-9843","observed_orcids":["https://orcid.org/0000-0001-8080-9843"]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"R. Dziadziuszko","raw_affiliation_strings":["University of Colorado Cancer Center, Aurora, CO; Christie Hospital, Manchester, United Kingdom; AstraZeneca, Macclesfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Cancer Center, Aurora, CO; Christie Hospital, Manchester, United Kingdom; AstraZeneca, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071851332","display_name":"Fred R. Hirsch","orcid":"https://orcid.org/0000-0002-6885-1894","observed_orcids":["https://orcid.org/0000-0002-6885-1894"]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"F. R. Hirsch","raw_affiliation_strings":["University of Colorado Cancer Center, Aurora, CO; Christie Hospital, Manchester, United Kingdom; AstraZeneca, Macclesfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Cancer Center, Aurora, CO; Christie Hospital, Manchester, United Kingdom; AstraZeneca, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024045160","display_name":"Marileila Varella\u2010Garcia","orcid":"https://orcid.org/0000-0002-2310-5863","observed_orcids":["https://orcid.org/0000-0002-2310-5863"]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"M. Varella-Garcia","raw_affiliation_strings":["University of Colorado Cancer Center, Aurora, CO; Christie Hospital, Manchester, United Kingdom; AstraZeneca, Macclesfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Cancer Center, Aurora, CO; Christie Hospital, Manchester, United Kingdom; AstraZeneca, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110052001","display_name":"N. Thatcher","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"N. Thatcher","raw_affiliation_strings":["University of Colorado Cancer Center, Aurora, CO; Christie Hospital, Manchester, United Kingdom; AstraZeneca, Macclesfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Cancer Center, Aurora, CO; Christie Hospital, Manchester, United Kingdom; AstraZeneca, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072962250","display_name":"Helen Mann","orcid":"https://orcid.org/0000-0001-9426-2332","observed_orcids":["https://orcid.org/0000-0001-9426-2332"]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"H. Mann","raw_affiliation_strings":["University of Colorado Cancer Center, Aurora, CO; Christie Hospital, Manchester, United Kingdom; AstraZeneca, Macclesfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Cancer Center, Aurora, CO; Christie Hospital, Manchester, United Kingdom; AstraZeneca, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001488061","display_name":"Claire L Watkins","orcid":"https://orcid.org/0000-0001-6475-2795","observed_orcids":["https://orcid.org/0000-0001-6475-2795"]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"C. Watkins","raw_affiliation_strings":["University of Colorado Cancer Center, Aurora, CO; Christie Hospital, Manchester, United Kingdom; AstraZeneca, Macclesfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Cancer Center, Aurora, CO; Christie Hospital, Manchester, United Kingdom; AstraZeneca, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042329520","display_name":"Georgina Speake","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"G. Speake","raw_affiliation_strings":["University of Colorado Cancer Center, Aurora, CO; Christie Hospital, Manchester, United Kingdom; AstraZeneca, Macclesfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Cancer Center, Aurora, CO; Christie Hospital, Manchester, United Kingdom; AstraZeneca, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111533109","display_name":"B. R. Holloway","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"B. Holloway","raw_affiliation_strings":["University of Colorado Cancer Center, Aurora, CO; Christie Hospital, Manchester, United Kingdom; AstraZeneca, Macclesfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Cancer Center, Aurora, CO; Christie Hospital, Manchester, United Kingdom; AstraZeneca, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210134151"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071670695","display_name":"Paul A. Bunn","orcid":"https://orcid.org/0000-0003-0518-5959","observed_orcids":["https://orcid.org/0000-0003-0518-5959"]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"P. A. Bunn","raw_affiliation_strings":["University of Colorado Cancer Center, Aurora, CO; Christie Hospital, Manchester, United Kingdom; AstraZeneca, Macclesfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Cancer Center, Aurora, CO; Christie Hospital, Manchester, United Kingdom; AstraZeneca, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210134151"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109210308","display_name":"Wilbur A. Franklin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210134151","display_name":"University of Colorado Cancer Center","ror":"https://ror.org/04cqn7d42","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134151"]}],"countries":["GB","US"],"is_corresponding":false,"raw_author_name":"W. A. Franklin","raw_affiliation_strings":["University of Colorado Cancer Center, Aurora, CO; Christie Hospital, Manchester, United Kingdom; AstraZeneca, Macclesfield, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Colorado Cancer Center, Aurora, CO; Christie Hospital, Manchester, United Kingdom; AstraZeneca, Macclesfield, United Kingdom","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210134151"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"18_suppl","first_page":"7576","last_page":"7576"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.9779999852180481},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9190000295639038},{"id":"https://openalex.org/keywords/antibody-comparison","display_name":"antibody comparison","score":0.6079999804496765},{"id":"https://openalex.org/keywords/cut-points","display_name":"cut points","score":0.5860000252723694},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.8090000152587891},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.6179999709129333},{"id":"https://openalex.org/keywords/survival-benefit","display_name":"survival benefit","score":0.6320000290870667},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.6980000138282776},{"id":"https://openalex.org/keywords/never-smokers","display_name":"never smokers","score":0.4729999899864197}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8261449337005615},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.7369261980056763},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.6313741207122803},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6222150325775146},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5858394503593445},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5261898636817932},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5209416151046753},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5166090130805969},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.44422733783721924},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.41379982233047485},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.41216087341308594},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3902103304862976},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3560578227043152},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.25169044733047485},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.20207852125167847},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2007.25.18_suppl.7576","doi":"https://doi.org/10.1200/jco.2007.25.18_suppl.7576","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2007.25.18_suppl.7576","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2051502146","https://openalex.org/W2166649051","https://openalex.org/W2244823046","https://openalex.org/W2152004755","https://openalex.org/W2003987759","https://openalex.org/W2395955403","https://openalex.org/W2311626768","https://openalex.org/W1969522977","https://openalex.org/W2589606748","https://openalex.org/W2074937243"],"abstract_inverted_index":{"7576":[0],"Background:":[1],"Tumor":[2],"tissues":[3],"obtained":[4],"from":[5,47],"the":[6,12,103,115,121,129,155,172,220,224,252,266,325],"ISEL":[7],"phase":[8],"III":[9],"trial":[10],"assessing":[11],"efficacy":[13],"of":[14,36,42,67,76,86,97,102,123,146,159,236,290,298,313,324],"gefitinib":[15,184,242],"vs":[16],"placebo":[17],"in":[18,53,183,234],"chemotherapy-pretreated":[19],"NSCLC":[20],"were":[21,148,162],"used":[22],"to":[23,150,197,210,243,288,317,331],"evaluate":[24],"two":[25],"Abs":[26,113],"(DAKO":[27],"and":[28,30,44,78,110,126,144,169,202,204,214,230,273,309],"Zymed)":[29],"assess":[31],"whether":[32],"different":[33],"cut":[34,74,95,191,217,254,278,315],"points":[35,192,218,316],"EGFR":[37,50,62,228,231],"protein":[38,51],"expression":[39,52],"improved":[40],"prediction":[41,297],"response":[43,181],"survival":[45,237,299],"benefit":[46,300],"gefitinib.":[48],"Methods:":[49],"tumor":[54,68,160],"samples":[55,161],"was":[56,260,270],"assessed":[57,106],"by":[58],"immunohistochemistry":[59],"using":[60,166,171],"DAKO":[61,108,167,194,221,284],"pharmDx":[63],"kit":[64],"(scoring":[65,84],"percent":[66],"cells":[69,88],"with":[70,107,120,132,189,193,205,219,245,283,306],"positive":[71,87,165,229,291],"staining,":[72,292],"predefined":[73,94],"point":[75,96,249,255,279],"=10%)":[77],"Zymed":[79,111,173,206,263,307],"monoclonal":[80],"Ab":[81,168,174,195,207,222,308],"clone":[82],"31G7":[83],"proportion":[85],"times":[89],"staining":[90,310],"intensity":[91],"[scale":[92],"0\u2013400],":[93],"=200).":[98],"Results:":[99],"Clinical":[100],"characteristics":[101],"patients":[104,233],"(pts)":[105],"(n=379)":[109],"(n=357)":[112],"reflected":[114],"overall":[116],"study":[117],"population":[118],"(N=1692)":[119],"exception":[122],"fewer":[124],"never-smokers":[125],"Asians.":[127],"Of":[128],"pts":[130,147,187,303],"evaluated":[131],"DAKO/Zymed":[133],"Abs,":[134],"females":[135],"represented":[136],"32%/31%;":[137],"never-smokers,":[138],"13%/14%;":[139],"Asians,":[140],"6%/4%;":[141],"adenocarcinomas,":[142],"44%/42%;":[143],"88%/88%":[145],"refractory":[149],"most":[151],"recent":[152],"chemotherapy.":[153],"With":[154],"above":[156],"criteria,":[157],"70%":[158],"scored":[163],"as":[164],"68%":[170],"(agreement":[175],"between":[176,200,212,227,268],"assessments":[177],"76%).":[178],"The":[179],"objective":[180],"rates":[182],"treated":[185],"EGFR-positive":[186],"defined":[188],"various":[190],"(=1%":[196],"=90%)":[198],"varied":[199],"8%":[201],"12%,":[203],"(score":[208],"=50":[209],"=350),":[211],"10%":[213,253],"13%.":[215],"Lower":[216],"provided":[223],"best":[225],"discrimination":[226,267,323],"negative":[232],"terms":[235],"hazard":[238],"ratios":[239],"(HRs)":[240],"comparing":[241],"placebo,":[244],"a":[246],"significant":[247,275,328],"treatment/cut":[248],"interaction":[250],"for":[251,262,276,301],"(p=0.049).":[256],"A":[257],"similar":[258],"trend":[259],"noted":[261],"Ab,":[264],"although":[265],"HRs":[269],"less":[271],"apparent":[272],"not":[274,321],"any":[277],"analyzed.":[280],"Conclusion:":[281],"Assessment":[282],"PharmDx":[285],"kit,":[286],"according":[287],"percentage":[289],"may":[293],"provide":[294],"more":[295],"accurate":[296],"gefitinib-treated":[302],"than":[304],"assessment":[305],"index.":[311],"Use":[312],"higher":[314],"define":[318],"positivity":[319],"does":[320],"improve":[322],"test.":[326],"No":[327],"financial":[329],"relationships":[330],"disclose.":[332]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}